Since DKSH launched PSPhere Lite+ as part of the PSPhere product portfolio in September 2021, we have rapidly rolled out Patient Access Programs (PAPs) across Asia Pacific markets. We identified the need for a standard and cost-effective solution for pharmaceutical companies to implement their Patient Support Programs (PSP). While our hypothesis is proving right, there is more to do in engaging patients and in helping them achieve better healthcare outcomes using PSPhere, our patient benefits and relationship management platform, built to solve the problem of administering beyond-the-pill solutions for patients.
